[1]FRANKLIN RA,LI MO.Ontogeny of tumor-associated macrophages and its implication in cancer regulation［J］.Trends Cancer,2016,2(1):20-34.
[2]HE Z,ZHANG S.Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment［J］.Front Immunol,2021,12:741305.
[3]ORECCHIONI M,GHOSHEH Y,PRAMOD AB,et al.Macrophage polarization:different gene signatures in M1(LPS+)vs.classically and M2(LPS-)vs.alternatively activated macrophages ［J］.Front Immunol,2019,10:1084.
[4]FUNES SC,RIOS M,ESCOBAR-VERA J,et al.Implications of macrophage polarization in autoimmunity ［J］.Immunology,2018,154(2):186-195.
[5]WANG Y,SMITH W,HAO D,et al.M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds ［J］.Int Immunopharmacol,2019,70:459-466.
[6]RHEE I.Diverse macrophages polarization in tumor microenvironment ［J］.Arch Pharm Res,2016,39(11):1588-1596.
[7]LOCATI M,CURTALE G,MANTOVANI A.Diversity,mechanisms,and significance of macrophage plasticity［J］.Annu Rev Pathol,2020,15:123-147.
[8]GUERRIERO JL.Macrophages:the road less traveled,changing anticancer therapy ［J］.Trends Mol Med,2018,24(5):472-489.
[9]LI J,LI L,LI Y,et al.Tumor-associated macrophage infiltration and prognosis in colorectal cancer:systematic review and meta-analysis［J］.Int J Colorectal Dis,2020,35(7):1203-1210.
[10]MALESCI A,BIANCHI P,CELESTI G,et al.Tumorassociated macrophages and response to 5-fluorouracil adjuvant therapy in stage Ⅲ colorectal cancer ［J］.Oncoimmunology,2017,6(12):1-11.
[11]YANG M,MCKAY D,POLLARD JW,et al.Diverse functions of macrophages in different tumor microenvironments ［J］.Cancer Res,2018,78(19):5492-5503.
[12]LARIONOVA I,CHERDYNTSEVA N,LIU TF,et al.Interaction of tumor-associated macrophages and cancer chemotherapy ［J］.Oncoimmunology,2019,8(7):1596004.
[13]ZHANG J,WANG H,WU H,et al.The functionalities and clinical significance of tumor-infiltrating immune cells in esophageal squamous cell carcinoma ［J］.Biomed Res Int,2021,2021:8635381.
[14]YAMAMOTO K,MAKINO T,SATO E,et al.Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer ［J］.Cancer Sci,2020,111(4):1103-1112.
[15]SCHIFFMANN LM,PLUM PS,FUCHS HF,et al.Tumor microenvironment of esophageal cancer ［J］.Cancers(Basel),2021,13(18):4678.
[16]FENG QY,CHANG WJ,MAO YH,et al.Tumor-associated macrophages as prognostic and predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage Ⅱ colon cancer ［J］.Clin Cancer Res,2019,25(13):3896-3907.
[17]LAN H,LIU Y,LIU J,et al.Tumor-associated macrophages promote oxaliplatin resistance via METTL3-mediated m6A of TRAF5 and necroptosis in colorectal cancer［J］.Mol Pharm,2021,18(3):1026-1037.
[18]LIU R,HU R,ZENG Y,et al.Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes:A gene expression-based computational study ［J］.Ebio Medicine,2020,51:102602.
[19]FAKIH M,OUYANG C,WANG CK,et al.Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome ［J］.J Clin Invest,2019,129(10):4464-4476.
[20]GURJAO C,LIU D,HOFREE M,et al.Intrinsic resistance to immune checkpoint blockade in a mismatch repair-deficient colorectal cancer ［J］.Cancer Immunol Res,2019,7(8):1230-1236.
[21]CANDIDO JB,MORTON JP,BAILEY P,et al.CSF1R+ macrophages sustain pancreatic tumor growth through T cell suppression and maintenance of key gene programs that define the squamous subtype ［J］.Cell Rep,2018,23(5):1448-1460.
[22]BLANDO J,SHARMA A,HIGA MG,et al.Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA asa potential target in pancreatic cancer ［J］.Proc Natl Acad Sci USA,2019,116(5):1692-1697.
[23]QUARANTA V,SCHMID MC.Macrophage-mediated subversion of anti-tumour immunity ［J］.Cells,2019,8(7):747.
[24]JIANG H,HEGDE S,DENARDO DG.Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy ［J］.Cancer Immunol Immunother,2017,66(8):1037-1048.
[25]WYNN TA,VANNELLA KM.Macrophages in tissue repair,regeneration,and fibrosis ［J］.Immunity,2016,44(3):450-462.
[26]TANG PM,NIKOLIC-PATERSON DJ,LAN HY.Macrophages:versatile players in renal inflammation and fibrosis ［J］.Nat Rev Nephrol,2019,15(3):144-158.
[27]DENARDO DG,RUFFELL B.Macrophages as regulators of tumour immunity and immunotherapy ［J］.Nat Rev Immunol,2019,19(6):369-382.
[28]NIELSEN SR,QUARANTA V,LINFORD A,et al.Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis ［J］.Nat Cell Biol,2016,18(5):549-560.
[29]ARLAUCKAS SP,GARRIS CS,KOHLER RH,et al.In vivo imaging reveals a tumor-associated macrophage mediated resistance pathway in anti-PD-1 therapy ［J］.Sci Transl Med,2017,9(389):eaal3604.
[30]FANG DD,TANG QQ,KONG YH,et al.MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment ［J］.J Immunother Cancer,2019,7(1):327.